Tagrisso 40 mg

Tagrisso 40 mg is a medicine authorised by Swissmedic under authorisation number 65872. The authorisation holder is AstraZeneca AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 11 July 2016 and the authorisation is valid without a time limit. ATC code L01EB04 places the medicine in the group Antineoplastic agents.

Dispensing category A
Authorisation number 65872
ATC L01EB04
Synthetic medicines

Authorisation data
Authorisation number	65872
Name	Tagrisso 40 mg
Full name	Tagrisso 40 mg, Filmtabletten
Authorisation holder	AstraZeneca AG
Medicinal product code	Synthetic medicines
Dispensing category	A · Prescription, not repeatable
ATC code	L01EB04
First authorisation	11 July 2016
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Tagrisso 40 mg, Filmtabletten	A	11 July 2016
2	Tagrisso 80 mg, Filmtabletten	A	11 July 2016

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	30	Tablette(n)	L01EB04	07.16.1.	A
2	30	Tablette(n)	L01EB04	07.16.1.	A

Scroll the table sideways

Other medicines from this authorisation holder

AxultaAuthorisation number 65402 · ATC A06AX04B Bricanyl TurbuhalerAuthorisation number 48943 · ATC R03AC03B Brilique 90 mgAuthorisation number 61389 · ATC B01AC24B Brilique 90 mgAuthorisation number 66822 · ATC B01AC24B Calquence 100 mgAuthorisation number 68817 · ATC L01EL02A Daxas 500 ugAuthorisation number 60484 · ATC R03DX07B Fasenra 30 mg /1 mlAuthorisation number 66582 · ATC R03DX10B Fasenra Pen 30 mg /1 mlAuthorisation number 67581 · ATC R03DX10B

Frequently asked questions

Is Tagrisso 40 mg authorised in Switzerland?

Yes. Tagrisso 40 mg is authorised by Swissmedic under authorisation number 65872, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Tagrisso 40 mg have?

Tagrisso 40 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Tagrisso 40 mg?

The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.